Affymetrix Expands Agrigenomics Genotyping Portfolio with New Targeted Sequencing Solution and Array Formats
January 07 2016 - 6:30AM
Business Wire
Affymetrix, Inc. (NASDAQ:AFFX) is introducing several new
agrigenomic genotyping solutions this week at the annual Plant and
Animal Genome Conference (PAG XXIV). Following the company’s
acquisition of Eureka Genomics in mid-2015, Affymetrix is
introducing Eureka™ Genotyping Solution for low-cost, low-plex
genotyping by sequencing (GBS). The company is also introducing two
new array configurations for the Axiom® genotyping platform,
providing customers with a complete range of options for varying
sample numbers and throughput goals.
Eureka Genotyping Solution is a new targeted genotyping by
sequencing solution that delivers high throughput sample processing
with low cost per sample. This is enabled by an innovative
multiplexed combination of allele and sample-specific barcodes
which support high sample plexing on a sequencer while delivering
high quality SNP analysis. The Eureka genotyping assay overcomes
the challenges associated with current GBS technologies which are
susceptible to variability in genomic reads and missing SNP
information, high cost, and has complex informatics analysis.
Customers can access the Eureka genotyping assay as a service
provided by Affymetrix Research Services Laboratory or as a
kit-based product to run in their own facility.
Complementing the Eureka genotyping offerings, the new
configurations of the Axiom array formats widen throughput choices
for the customer. The new 24-sample configuration on the
high-density Axiom 96 platform can interrogate upward of 800,000
markers while the new 96-sample configuration on the Axiom 384 HT
platform can assay about 50,000 genetic variants. These new array
configurations enable customers to improve the efficiency of their
workflow to match sample availability and turn-around time. These
new configurations extend the existing 96- and 384-sample Axiom
formats available as catalog arrays off the shelf or as custom
arrays delivered in six weeks or less.
"The new Eureka Genotyping Solution and Axiom array
configurations allow customers to run a broad spectrum of
genotyping applications from marker validation to routine
screening," said Laurent Bellon, Ph.D., senior vice president and
general manager, Genotyping Business Unit at Affymetrix. "Customers
today are seeking flexible, high-throughput solutions that can
deliver targeted, custom SNP panels containing critical ‘must-have’
markers associated with specific traits. The Eureka genotyping
solution addresses this gap in current sequencing technologies by
delivering targeted genotyping for thousands of samples per week in
an easy and affordable manner."
Agricultural genotyping solutions from Affymetrix offer plant
and animal genotyping scientists customized, cost-effective,
automated genotyping tools for the highly accurate identification,
validation, and screening of markers associated with desired
genetic traits. Affymetrix is the leader in customization of
agriculture genotyping arrays and also offers catalog arrays for a
variety of plants and animals that were designed under the Expert
Design Program.
For more information on the Axiom genotyping platform for
agrigenomics applications, please visit
www.affymetrix.com/agrigenotyping.
About Affymetrix
Affymetrix technologies enable multiplex and simultaneous
analysis of biological systems at the cell, protein, and gene
level, facilitating the rapid translation of benchtop research into
clinical and routine use for human health and wellness. Affymetrix
provides leadership and support, partnering with customers in
pharmaceutical, diagnostic, and biotechnology companies, as well as
leading academic, government, and nonprofit research institutes in
their quest to use biology for a better world. More than 2,300
microarray systems have been shipped around the world and more than
94,000 peer-reviewed papers have been published citing Affymetrix
technologies. Affymetrix is headquartered in Santa Clara,
California, and has manufacturing facilities in Cleveland, San
Diego, Vienna, and Singapore. Affymetrix has about 1,100 employees
and maintains sales and distribution operations worldwide. For more
information about Affymetrix, please visit www.affymetrix.com.
Forward-looking statements
All statements in this press release that are not historical are
"forward-looking statements" within the meaning of Section 21E of
the Securities Exchange Act as amended, including statements
regarding Affymetrix' "expectations," "beliefs," "hopes,"
"intentions," "strategies," or the like. Such statements are
subject to risks and uncertainties that could cause actual results
to differ materially for Affymetrix from those projected. These and
other risk factors are discussed in Affymetrix' Form 10-K for the
year ended December 31, 2014, and other SEC reports for subsequent
quarterly periods.
PLEASE NOTE: Affymetrix, the Affymetrix logo, Axiom, and
Eureka trademarks are the property of Affymetrix, Inc. All other
trademarks are the property of their respective owners.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160107005399/en/
Affymetrix, Inc.Media Contact:Mindy Lee-Olsen,
408-731-5523Vice President, Marketing
Servicesmindy_lee-olsen@affymetrix.comorInvestor
Contact:Doug Farrell, 408-731-5285Vice President, Investor
Relationsdoug_farrell@affymetrix.com
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jul 2023 to Jul 2024